M5542

· Merck Healthcare KGaA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for M5542, covering 2026-04-01 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Single Ascending Doses (SAD) of M5542 in Healthy Participants [Phase 1]